KZA kazia therapeutics limited
Add to My Watchlist 0.00% ! 8.0¢

Ann: In-licencing of Phase II-ready molecule - presentation-NRT.AX, page-3

  1. novogenbuyer
    856 Posts.
    lightbulb Created with Sketch. 356
    clock Created with Sketch.
    31/10/16
    09:52
    Post #: 20241455
    I assume they (Roche) have more candidates than they can handle at the moment. They will earn money if it is successfully developed due to royalties and milestones. However, does NRT really have this kind of money right now? Seems to overlap with Trilexium's target, too. I don't really understand what's going on here, and I'm confused whether this is a good thing or not.
    Last edited by novogenbuyer: 31/10/16
    NRT Price at posting: 8.1¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 11  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS Paris Gold Project Drilling Underway Testing High-Grade Zones
right-arrow Created with Sketch.
NEWS R&D Tax Refund of $5.8M Received by Imugene to Support Clinical Development
right-arrow Created with Sketch.
NEWS More Outstanding Gallium Assay Results for Nimy at Block 3
right-arrow Created with Sketch.
NEWS Austral Resources to Acquire Rocklands to Transform North-West Queensland Copper
right-arrow Created with Sketch.
NEWS Drilling Commences at Leinster South Project in WA
right-arrow Created with Sketch.
NEWS MTM Successful Uplisting Commences Trading on OTCQX Market in US
right-arrow Created with Sketch.
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.